IN188338B - - Google Patents

Info

Publication number: IN188338B
Authority: IN; India

Application number

Other languages

English (en)

Inventor

Jeffrey Charles Boehm

Joseph Sisko

Zhi-Qiang Peng

Jerry Leroy Adams

Timothy F Gallagher

Ravi Shanker Garigipati

John Cheung-Lun Lee

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-01-09

Filing date

2000-01-27

Publication date

2002-09-07

2000-01-27 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2000-01-27 Priority to IN60DE2000 priority Critical patent/IN188338B/en

2002-09-07 Publication of IN188338B publication Critical patent/IN188338B/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Virology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pulmonology (AREA)
Hematology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Dermatology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Vascular Medicine (AREA)
Toxicology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Tropical Medicine & Parasitology (AREA)
Psychiatry (AREA)

IN60DE2000 1995-01-09 2000-01-27 IN188338B (ru)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
IN60DE2000 IN188338B (ru)	1995-01-09	2000-01-27

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US36996495A	1995-01-09	1995-01-09
US08/472,366 US5593992A (en)	1993-07-16	1995-06-07	Compounds
IN11DE1996 IN184957B (ru)	1995-01-09	1996-01-03
IN60DE2000 IN188338B (ru)	1995-01-09	2000-01-27

Publications (1)

Publication Number	Publication Date
IN188338B true IN188338B (ru)	2002-09-07

Family

ID=27004764

Family Applications (3)

Application Number	Title	Priority Date
IN11DE1996 IN184957B (ru)	1995-01-09	1996-01-03
IN60DE2000 IN188338B (ru)	1995-01-09	2000-01-27
IN61DE2000 IN188339B (ru)	1995-01-09	2000-01-27

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
IN11DE1996 IN184957B (ru)	1995-01-09	1996-01-03

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IN61DE2000 IN188339B (ru)	1995-01-09	2000-01-27

Country Status (34)

Country	Link
US (5)	US5593992A (ru)
EP (2)	EP0809499B1 (ru)
JP (2)	JP3330952B2 (ru)
CN (1)	CN1138546C (ru)
AP (1)	AP1270A (ru)
AR (1)	AR002267A1 (ru)
AT (1)	ATE254613T1 (ru)
AU (1)	AU705207C (ru)
BG (1)	BG63769B1 (ru)
BR (1)	BR9606904A (ru)
CA (1)	CA2209938A1 (ru)
CZ (1)	CZ215897A3 (ru)
DE (1)	DE69630777T2 (ru)
DK (1)	DK0809499T3 (ru)
DZ (1)	DZ1961A1 (ru)
ES (1)	ES2210348T3 (ru)
FI (1)	FI972901A (ru)
HK (1)	HK1003623A1 (ru)
HU (1)	HUP9702409A3 (ru)
ID (3)	ID23599A (ru)
IL (7)	IL134324A (ru)
IN (3)	IN184957B (ru)
MA (1)	MA23770A1 (ru)
MX (1)	MX9705142A (ru)
NO (3)	NO973167L (ru)
NZ (1)	NZ301204A (ru)
OA (1)	OA10738A (ru)
PL (1)	PL322249A1 (ru)
PT (1)	PT809499E (ru)
RU (2)	RU2196139C2 (ru)
SI (1)	SI0809499T1 (ru)
SK (1)	SK90297A3 (ru)
TW (1)	TW523511B (ru)
WO (1)	WO1996021452A1 (ru)

Families Citing this family (116)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5916891A (en)	1992-01-13	1999-06-29	Smithkline Beecham Corporation	Pyrimidinyl imidazoles
WO1995007922A1 (en) *	1993-09-17	1995-03-23	Smithkline Beecham Corporation	Drug binding protein
US6203803B1 (en)	1994-12-14	2001-03-20	Societe L'oreal S.A.	Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained
NZ302117A (en) *	1995-01-12	1999-10-28	Smithkline Beecham Corp	1-cycloalkyl or cycloalkylalkyl 4,5-trisubstituted imidazole derivatives and medicaments
EP0737471A3 (fr) *	1995-04-10	2000-12-06	L'oreal	Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
US6369068B1 (en)	1995-06-07	2002-04-09	Smithkline Beecham Corporation	Amino substituted pyrimidine containing compounds
US5658903A (en) *	1995-06-07	1997-08-19	Smithkline Beecham Corporation	Imidazole compounds, compositions and use
US5739143A (en) *	1995-06-07	1998-04-14	Smithkline Beecham Corporation	Imidazole compounds and compositions
FR2740341B1 (fr) *	1995-10-26	1997-12-19	Oreal	Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
ZA9610687B (en) *	1995-12-22	1997-09-29	Smithkline Beecham Corp	Novel synthesis.
US6046208A (en) *	1996-01-11	2000-04-04	Smithkline Beecham Corporation	Substituted imidazole compounds
US5977103A (en) *	1996-01-11	1999-11-02	Smithkline Beecham Corporation	Substituted imidazole compounds
AP9700912A0 (en) *	1996-01-11	1997-01-31	Smithkline Beecham Corp	Novel cycloalkyl substituted imidazoles
ZA97175B (en) *	1996-01-11	1997-11-04	Smithkline Beecham Corp	Novel substituted imidazole compounds.
EP1005343A4 (en) *	1996-03-08	2000-06-07	Smithkline Beecham Corp	USE OF CSAIDS AS ANGIOGENESIS INHIBITORS
WO1997035856A1 (en) *	1996-03-25	1997-10-02	Smithkline Beecham Corporation	Novel treatment for cns injuries
WO1998007425A1 (en)	1996-08-21	1998-02-26	Smithkline Beecham Corporation	Imidazole compounds, compositions and use
JP2001506980A (ja)	1996-11-19	2001-05-29	アムジエン・インコーポレーテツド	アリールおよびヘテロアリール置換縮合ピロール抗炎症剤
US6096753A (en)	1996-12-05	2000-08-01	Amgen Inc.	Substituted pyrimidinone and pyridone compounds and methods of use
US6410729B1 (en)	1996-12-05	2002-06-25	Amgen Inc.	Substituted pyrimidine compounds and methods of use
US5929076A (en) *	1997-01-10	1999-07-27	Smithkline Beecham Corporation	Cycloalkyl substituted imidazoles
AP999A (en) *	1997-01-10	2001-08-11	Smithkline Beecham Corp	Novel substituted imidazole compounds.
US6432947B1 (en)	1997-02-19	2002-08-13	Berlex Laboratories, Inc.	N-heterocyclic derivatives as NOS inhibitors
BR9808998A (pt)	1997-04-24	2000-08-08	Ortho Mcneil Pharm Inc	Imidazóis substituìdos úteis no tratamento de doenças inflamatórias
US6514977B1 (en)	1997-05-22	2003-02-04	G.D. Searle & Company	Substituted pyrazoles as p38 kinase inhibitors
US6979686B1 (en)	2001-12-07	2005-12-27	Pharmacia Corporation	Substituted pyrazoles as p38 kinase inhibitors
BR9809451A (pt) *	1997-05-22	2000-06-20	Searle & Co	Pirazóis substituìdos com 3(5)-heteroarila como inibidores de quinase p38.
EP1019394A1 (en)	1997-05-22	2000-07-19	G.D. Searle & Co.	PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS
US6087496A (en)	1998-05-22	2000-07-11	G. D. Searle & Co.	Substituted pyrazoles suitable as p38 kinase inhibitors
EP0988301B1 (en)	1997-06-12	2006-08-09	Aventis Pharma Limited	Imidazolyl-cyclic acetals
CA2294057A1 (en)	1997-06-13	1998-12-17	Smithkline Beecham Corporation	Novel pyrazole and pyrazoline substituted compounds
AU8154998A (en)	1997-06-19	1999-01-04	Smithkline Beecham Corporation	Novel aryloxy substituted pyrimidine imidazole compounds
IL133766A0 (en) *	1997-06-30	2001-04-30	Ortho Mcneil Pharm Inc	2-substituted imidazoles useful in the treatment of inflammatory diseases
US7301021B2 (en) *	1997-07-02	2007-11-27	Smithkline Beecham Corporation	Substituted imidazole compounds
CA2295762A1 (en) *	1997-07-02	1999-01-14	Ravi Shanker Garigipati	Novel cycloalkyl substituted imidazoles
AR016294A1 (es) *	1997-07-02	2001-07-04	Smithkline Beecham Corp	Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion
US6562832B1 (en)	1997-07-02	2003-05-13	Smithkline Beecham Corporation	Substituted imidazole compounds
TW517055B (en) *	1997-07-02	2003-01-11	Smithkline Beecham Corp	Novel substituted imidazole compounds
US6489325B1 (en)	1998-07-01	2002-12-03	Smithkline Beecham Corporation	Substituted imidazole compounds
EP1041989A4 (en) *	1997-10-08	2002-11-20	Smithkline Beecham Corp	NEW SUBSTITUTED CYCLOALCENYL COMPOUNDS
JP2001519381A (ja) *	1997-10-10	2001-10-23	インペリアル・カレッジ・イノベイションズ・リミテッド	子宮収縮管理のためのｃｓａｉｄｔｍ化合物の使用
US6022884A (en)	1997-11-07	2000-02-08	Amgen Inc.	Substituted pyridine compounds and methods of use
US7041694B1 (en)	1997-12-17	2006-05-09	Cornell Research Foundation, Inc.	Cyclooxygenase-2 inhibition
JP2001526230A (ja) *	1997-12-19	2001-12-18	スミスクライン・ビーチャム・コーポレイション	ヘテロアリール置換イミダゾール化合物、その医薬組成物および使用
CA2332402A1 (en)	1998-05-22	1999-12-02	Susan B. Dillon	Novel 2-alkyl substituted imidazole compounds
US6858617B2 (en)	1998-05-26	2005-02-22	Smithkline Beecham Corporation	Substituted imidazole compounds
EP1082320A4 (en) *	1998-05-26	2001-11-21	Smithkline Beecham Corp	NEW SUBSTITUTED IMIDAZOLE COMPOUNDS
AU4395399A (en) *	1998-07-02	2000-01-24	Sankyo Company Limited	Five-membered heteroaryl compounds
US6207687B1 (en) *	1998-07-31	2001-03-27	Merck & Co., Inc.	Substituted imidazoles having cytokine inhibitory activity
ATE266399T1 (de) *	1998-08-20	2004-05-15	Smithkline Beecham Corp	Neue substituierte triazolverbindungen
AU1909200A (en)	1998-11-04	2000-05-22	Smithkline Beecham Corporation	Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
US6239279B1 (en)	1998-12-16	2001-05-29	Smithkline Beecham Corporation	Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives
JP2002534385A (ja)	1999-01-08	2002-10-15	スミスクライン・ビーチャム・コーポレイション	新規化合物
US6930101B1 (en)	1999-05-17	2005-08-16	The Regents Of The University Of California	Thiazolopyrimidines useful as TNFα inhibitors
JP2003502424A (ja) *	1999-06-17	2003-01-21	シオノギバイオリサーチコーポレイション	Ｉｌ−１２産生の阻害物質
US7122666B2 (en)	1999-07-21	2006-10-17	Sankyo Company, Limited	Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
IL137365A0 (en) *	1999-07-21	2001-07-24	Sankyo Co	Heteroaryl-substituted pyrrole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
US6759410B1 (en) *	1999-11-23	2004-07-06	Smithline Beecham Corporation	3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
ATE296809T1 (de)	1999-11-23	2005-06-15	Smithkline Beecham Corp	3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren
WO2001038312A1 (en)	1999-11-23	2001-05-31	Smithkline Beecham Corporation	3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS
EP1233950B1 (en)	1999-11-23	2005-10-05	Smithkline Beecham Corporation	3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
US20020002169A1 (en)	1999-12-08	2002-01-03	Griffin John H.	Protein kinase inhibitors
ATE283048T1 (de) *	1999-12-08	2004-12-15	Pharmacia Corp	Cyclooxygenase-2 hemmer enthaltende zusammensetzungen mit schnellem wirkungseintritt
US7235551B2 (en) *	2000-03-02	2007-06-26	Smithkline Beecham Corporation	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
US6525051B2 (en)	2000-03-27	2003-02-25	Schering Aktiengesellschaft	N-heterocyclic derivatives as NOS inhibitors
PE20020146A1 (es) *	2000-07-13	2002-03-31	Upjohn Co	Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
CA2414674A1 (en) *	2000-07-13	2002-01-24	Pharmacia Corporation	Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
JP2004510705A (ja)	2000-07-20	2004-04-08	ラウラス　エイエス	方法
CZ20031125A3 (cs) *	2000-10-23	2003-10-15	Smithkline Beecham Corporation	Nové sloučeniny
US7115565B2 (en) *	2001-01-18	2006-10-03	Pharmacia & Upjohn Company	Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
WO2002057265A1 (fr) *	2001-01-22	2002-07-25	Sankyo Company, Limited	Composes substitues avec des groupes amines bicycliques
CN1781903A (zh)	2001-03-26	2006-06-07	奥索-麦克尼尔药品公司	制备四取代咪唑衍生物及其新型晶体结构的方法
US7695736B2 (en)	2001-04-03	2010-04-13	Pfizer Inc.	Reconstitutable parenteral composition
WO2002094267A1 (fr) *	2001-05-24	2002-11-28	Sankyo Company, Limited	Preparation pharmaceutique pour prevenir ou traiter l'arthrite
UA80682C2 (en) *	2001-08-06	2007-10-25	Pharmacia Corp	Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
HUP0401949A3 (en) *	2001-10-22	2009-07-28	Mitsubishi Tanabe Pharma Corp	4-imidazolin-2-one derivatives
AR039241A1 (es) *	2002-04-04	2005-02-16	Biogen Inc	Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
US6982259B2 (en) *	2002-04-30	2006-01-03	Schering Aktiengesellschaft	N-heterocyclic derivatives as NOS inhibitors
DE60310730T2 (de)	2002-07-09	2007-05-16	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
AU2003262911A1 (en)	2002-08-29	2004-03-19	Scios Inc.	Methods of promoting osteogenesis
UA80295C2 (en) *	2002-09-06	2007-09-10	Biogen Inc	Pyrazolopyridines and using the same
UA80296C2 (en) *	2002-09-06	2007-09-10	Biogen Inc	Imidazolopyridines and methods of making and using the same
WO2004041210A2 (en)	2002-11-05	2004-05-21	Smithkline Beecham Corporation	Antibacterial agents
KR101060215B1 (ko) *	2002-12-16	2011-08-29	아스트라제네카 유케이 리미티드	피리미딘 화합물의 제조 방법
CL2004000234A1 (es) *	2003-02-12	2005-04-15	Biogen Idec Inc	Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid
CL2004000366A1 (es) *	2003-02-26	2005-01-07	Pharmacia Corp Sa Organizada B	USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
US7244441B2 (en)	2003-09-25	2007-07-17	Scios, Inc.	Stents and intra-luminal prostheses containing map kinase inhibitors
WO2005058834A2 (en) *	2003-12-12	2005-06-30	Wyeth	Quinolines useful in treating cardiovascular disease
WO2005060967A1 (en) *	2003-12-18	2005-07-07	Pfizer Products Inc.	METHODS OF TREATING ACUTE INFLAMMATION IN ANIMALS WITH p38 MAP KINASE INHIBITORS
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
KR101102800B1 (ko) *	2004-08-31	2012-01-05	산요가세이고교 가부시키가이샤	계면 활성제
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
EP1676574A3 (en)	2004-12-30	2006-07-26	Johnson & Johnson Vision Care, Inc.	Methods for promoting survival of transplanted tissues and cells
EA200702073A1 (ru) *	2005-03-25	2008-12-30	Глэксо Груп Лимитед	Способ получения пиридо[2,3-d]пиримидин-7-оновых и 3,4-дигидропиримидо[4,5-d]пиримидин-2(1н)-оновых производных
AR053346A1 (es) *	2005-03-25	2007-05-02	Glaxo Group Ltd	Compuesto derivado de 8h -pirido (2,3-d) pirimidin -7 ona 2,4,8- trisustituida composicion farmaceutica y uso para preparar una composicion para tratamiento y profilxis de una enfermedad mediada por la quinasa csbp/ rk/p38
US20060252807A1 (en) *	2005-04-22	2006-11-09	Kalypsys, Inc.	Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
US20060281788A1 (en)	2005-06-10	2006-12-14	Baumann Christian A	Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
JP5331681B2 (ja)	2006-04-20	2013-10-30	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	ｃ−ｆｍｓキナーゼの阻害剤
WO2007124316A1 (en)	2006-04-20	2007-11-01	Janssen Pharmaceutica N.V.	Heterocyclic compounds as inhibitors of c-fms kinase
US8697716B2 (en)	2006-04-20	2014-04-15	Janssen Pharmaceutica Nv	Method of inhibiting C-KIT kinase
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
EP2173876A4 (en) *	2007-06-05	2012-05-30	Western States Biopharmaceuticals Inc	SURFACE MOLECULES INDUCING T CELL CYTOKINE AND METHODS OF USE
JO3240B1 (ar)	2007-10-17	2018-03-08	Janssen Pharmaceutica Nv	c-fms مثبطات كيناز
EP2393514B1 (en) *	2009-02-06	2017-12-20	Sichuan Huiyu Pharmaceutical Co., Ltd.	Dual inhibition of immunophilin/cyclophilin and emmprin immunoglobulin receptor superfamily members
EP2882757B1 (en)	2012-08-07	2016-10-05	Janssen Pharmaceutica, N.V.	Process for the preparation of heterocyclic ester derivatives
JOP20180012A1 (ar)	2012-08-07	2019-01-30	Janssen Pharmaceutica Nv	عملية السلفنة باستخدام نونافلوروبوتانيسولفونيل فلوريد
BR112015003395A2 (pt) *	2012-08-16	2017-07-04	Janssen Pharmaceutica Nv	pirazóis substituídos como bloqueadores de canal de cálcio de tipo-n
US9453002B2 (en)	2013-08-16	2016-09-27	Janssen Pharmaceutica Nv	Substituted imidazoles as N-type calcium channel blockers
CN104402823B (zh) *	2014-11-05	2016-03-23	上海浩登材料科技有限公司	一种1，2-二甲基咪唑的制备方法
CN104496906B (zh) *	2014-11-05	2016-03-23	上海浩登材料科技有限公司	一种咪唑的制备方法
EP3273955A4 (en)	2015-03-23	2019-05-01	The University of Melbourne	TREATMENT OF RESPIRATORY DISEASES
CN110753688A (zh) *	2017-05-03	2020-02-04	墨尔本大学	用于治疗呼吸***疾病的化合物
US10342786B2 (en)	2017-10-05	2019-07-09	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
CN114732910A (zh)	2017-10-05	2022-07-12	弗尔康医疗公司	P38激酶抑制剂降低dux4和下游基因表达以用于治疗fshd
US20220002269A1 (en) *	2018-11-07	2022-01-06	The University Of Melbourne	Novel compounds for the treatment of respiratory diseases
FR3097222B1 (fr) *	2019-06-11	2021-05-28	Michelin & Cie	Nouveaux composes 1,3-dipolaires comprenant un heterocycle aromatique et un cycle imidazole

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2011376B2 (de) *	1969-03-11	1975-08-28	Glaxo Laboratories Ltd., Greenford, Middlesex (Grossbritannien)	Verfahren zur Herstellung von 7beta-Acylamido-S-methylceph-S-em^-carbonsäureestern
US3707475A (en) *	1970-11-16	1972-12-26	Pfizer	Antiinflammatory imidazoles
US3940486A (en) *	1971-05-10	1976-02-24	Ciba-Geigy Corporation	Imidazole derivatives in the treatment of pain
US3929807A (en) *	1971-05-10	1975-12-30	Ciba Geigy Corp	2-Substituted-4(5)-(aryl)-5(4)-(2,3 or -4-pyridyl)-imidazoles
US4058614A (en) *	1973-12-04	1977-11-15	Merck & Co., Inc.	Substituted imidazole compounds and therapeutic compositions therewith
US4199592A (en) *	1978-08-29	1980-04-22	E. I. Du Pont De Nemours And Company	Antiinflammatory 4,5-diaryl-2-nitroimidazoles
CA1175431A (en) *	1980-07-25	1984-10-02	Alfred Sallmann	Tri-substituted imidazole derivatives, processes for their manufacture, pharmaceutical preparations containing them, and their use
US4503065A (en) *	1982-08-03	1985-03-05	E. I. Du Pont De Nemours And Company	Antiinflammatory 4,5-diaryl 1-2-halo imidazoles
US4565875A (en) *	1984-06-27	1986-01-21	Fmc Corporation	Imidazole plant growth regulators
US4686231A (en) *	1985-12-12	1987-08-11	Smithkline Beckman Corporation	Inhibition of 5-lipoxygenase products
IE59893B1 (en) *	1986-04-16	1994-04-20	Roussel Uclaf	Process for the manufacture of n-(sulfonylmethyl) formamides
IL83467A0 (en) *	1986-08-15	1988-01-31	Fujisawa Pharmaceutical Co	Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same
KR930703321A (ko) *	1990-12-13	1993-11-29	스튜어트 알. 슈터	신규한 사이토킨 억제성 소염 의약
EP0563286A4 (en) *	1990-12-13	1995-01-11	Smithkline Beecham Corp	Novel csaids
DE69322254T2 (de) *	1992-01-13	1999-04-29	Smithkline Beecham Corp	Pyridyl-substituierte imidazole
IL104369A0 (en) *	1992-01-13	1993-05-13	Smithkline Beecham Corp	Novel compounds and compositions
IL110296A (en) *	1993-07-16	1999-12-31	Smithkline Beecham Corp	Imidazole compounds process for their preparation and pharmaceutical compositions containing them
AU7629594A (en) *	1993-07-21	1995-02-20	Smithkline Beecham Corporation	Imidazoles for treating cytokine mediated disease
NZ302117A (en) *	1995-01-12	1999-10-28	Smithkline Beecham Corp	1-cycloalkyl or cycloalkylalkyl 4,5-trisubstituted imidazole derivatives and medicaments

1995
- 1995-06-07 US US08/472,366 patent/US5593992A/en not_active Expired - Lifetime
- 1995-12-19 IL IL13432495A patent/IL134324A/xx unknown
- 1995-12-19 IL IL11645595A patent/IL116455A/en not_active IP Right Cessation
- 1995-12-19 IL IL13432295A patent/IL134322A/en not_active IP Right Cessation
- 1995-12-19 IL IL13432395A patent/IL134323A/en not_active IP Right Cessation
1996
- 1996-01-03 IN IN11DE1996 patent/IN184957B/en unknown
- 1996-01-05 MA MA24125A patent/MA23770A1/fr unknown
- 1996-01-05 AR ARP960100903A patent/AR002267A1/es unknown
- 1996-01-06 DZ DZ960002A patent/DZ1961A1/fr active
- 1996-01-09 ID IDP990848D patent/ID23599A/id unknown
- 1996-01-09 ID IDP990849D patent/ID23597A/id unknown
- 1996-01-09 ID IDP990850D patent/ID23273A/id unknown
- 1996-01-11 BR BR9606904A patent/BR9606904A/pt active Search and Examination
- 1996-01-11 NZ NZ301204A patent/NZ301204A/xx unknown
- 1996-01-11 CN CNB961922982A patent/CN1138546C/zh not_active Expired - Fee Related
- 1996-01-11 SK SK902-97A patent/SK90297A3/sk unknown
- 1996-01-11 SI SI9630660T patent/SI0809499T1/xx unknown
- 1996-01-11 DK DK96902151T patent/DK0809499T3/da active
- 1996-01-11 JP JP52186296A patent/JP3330952B2/ja not_active Expired - Fee Related
- 1996-01-11 WO PCT/US1996/000546 patent/WO1996021452A1/en not_active Application Discontinuation
- 1996-01-11 CA CA002209938A patent/CA2209938A1/en not_active Abandoned
- 1996-01-11 CZ CZ972158A patent/CZ215897A3/cs unknown
- 1996-01-11 AU AU46572/96A patent/AU705207C/en not_active Ceased
- 1996-01-11 EP EP96902151A patent/EP0809499B1/en not_active Expired - Lifetime
- 1996-01-11 ES ES96902151T patent/ES2210348T3/es not_active Expired - Lifetime
- 1996-01-11 MX MX9705142A patent/MX9705142A/es unknown
- 1996-01-11 AT AT96902151T patent/ATE254613T1/de not_active IP Right Cessation
- 1996-01-11 RU RU97113753/04A patent/RU2196139C2/ru not_active IP Right Cessation
- 1996-01-11 HU HU9702409A patent/HUP9702409A3/hu unknown
- 1996-01-11 DE DE69630777T patent/DE69630777T2/de not_active Expired - Fee Related
- 1996-01-11 PL PL96322249A patent/PL322249A1/xx unknown
- 1996-01-11 AP APAP/P/1997/001021A patent/AP1270A/en active
- 1996-01-11 EP EP02078189A patent/EP1264827A1/en not_active Withdrawn
- 1996-01-11 PT PT96902151T patent/PT809499E/pt unknown
- 1996-03-18 TW TW085103208A patent/TW523511B/zh not_active IP Right Cessation
- 1996-08-21 US US08/702,250 patent/US5663334A/en not_active Expired - Lifetime
1997
- 1997-03-17 US US08/819,619 patent/US6103936A/en not_active Expired - Fee Related
- 1997-07-02 BG BG101727A patent/BG63769B1/bg unknown
- 1997-07-08 FI FI972901A patent/FI972901A/fi not_active IP Right Cessation
- 1997-07-08 NO NO973167A patent/NO973167L/no unknown
- 1997-07-09 OA OA70045A patent/OA10738A/en unknown
1998
- 1998-04-09 HK HK98103016A patent/HK1003623A1/xx not_active IP Right Cessation
2000
- 2000-01-27 IN IN60DE2000 patent/IN188338B/en unknown
- 2000-01-27 IN IN61DE2000 patent/IN188339B/en unknown
- 2000-02-01 IL IL13432300A patent/IL134323A0/xx unknown
- 2000-02-01 IL IL13432200A patent/IL134322A0/xx unknown
- 2000-02-01 IL IL13432400A patent/IL134324A0/xx unknown
- 2000-02-11 US US09/502,763 patent/US6222036B1/en not_active Expired - Fee Related
2001
- 2001-02-27 US US09/795,009 patent/US20020188122A1/en not_active Abandoned
- 2001-07-16 JP JP2001215404A patent/JP2002105047A/ja active Pending
- 2001-12-19 NO NO20016226A patent/NO20016226D0/no not_active Application Discontinuation
- 2001-12-19 NO NO20016225A patent/NO20016225D0/no not_active Application Discontinuation
2002
- 2002-08-15 RU RU2002122174/14A patent/RU2002122174A/ru not_active Application Discontinuation

Also Published As

Publication number	Publication date
BG101727A (en)	1998-03-31
EP0809499B1 (en)	2003-11-19
ES2210348T3 (es)	2004-07-01
RU2002122174A (ru)	2004-02-27
EP1264827A1 (en)	2002-12-11
HUP9702409A3 (en)	1999-06-28
JP2002105047A (ja)	2002-04-10
IL116455A0 (en)	1996-03-31
NO973167L (no)	1997-09-08
US6103936A (en)	2000-08-15
MA23770A1 (fr)	1996-10-01
AP1270A (en)	2004-04-16
CN1177299A (zh)	1998-03-25
DK0809499T3 (da)	2004-03-29
AR002267A1 (es)	1998-03-11
OA10738A (en)	2002-12-11
ID23599A (id)	1996-10-10
HUP9702409A2 (hu)	1999-05-28
IL134323A (en)	2001-11-25
AU705207C (en)	2002-09-19
US5663334A (en)	1997-09-02
JP3330952B2 (ja)	2002-10-07
ID23597A (id)	1996-10-10
IL134324A (en)	2001-08-26
PT809499E (pt)	2004-04-30
FI972901A0 (fi)	1997-07-08
BG63769B1 (bg)	2002-12-29
ATE254613T1 (de)	2003-12-15
BR9606904A (pt)	1997-10-21
CA2209938A1 (en)	1996-07-18
FI972901A (fi)	1997-09-08
RU2196139C2 (ru)	2003-01-10
MX9705142A (es)	1997-10-31
ID23273A (id)	1996-10-10
NO20016225D0 (no)	2001-12-19
US5593992A (en)	1997-01-14
IL134322A0 (en)	2001-04-30
DE69630777D1 (de)	2003-12-24
CN1138546C (zh)	2004-02-18
IL134323A0 (en)	2001-04-30
DE69630777T2 (de)	2004-07-29
IL134324A0 (en)	2001-04-30
NO20016226D0 (no)	2001-12-19
WO1996021452A1 (en)	1996-07-18
EP0809499A1 (en)	1997-12-03
EP0809499A4 (en)	1998-10-14
DZ1961A1 (fr)	2002-02-17
US6222036B1 (en)	2001-04-24
NO973167D0 (no)	1997-07-08
PL322249A1 (en)	1998-01-19
AU4657296A (en)	1996-07-31
NO20016226L (no)	1997-09-08
CZ215897A3 (cs)	1998-04-15
NO20016225L (no)	1997-09-08
AU705207B2 (en)	1999-05-20
SI0809499T1 (en)	2004-04-30
AP9701021A0 (en)	1997-07-31
IN184957B (ru)	2000-10-07
NZ301204A (en)	1999-05-28
HK1003623A1 (en)	1999-02-12
SK90297A3 (en)	1998-01-14
IL134322A (en)	2001-09-13
TW523511B (en)	2003-03-11
JPH10512555A (ja)	1998-12-02
US20020188122A1 (en)	2002-12-12
IL116455A (en)	2001-07-24
IN188339B (ru)	2002-09-07

Publication	Publication Date	Title
DE69638352D1 (ru)	2011-05-19
DE69637714D1 (ru)	2008-11-27
IN184957B (ru)	2000-10-07
BRPI9612258B1 (ru)	2011-05-31
BRPI9612138B1 (ru)	2009-09-22
DK143195A (ru)	1997-05-04
IN188016B (ru)	2002-08-10
CH0741373H1 (ru)	2011-10-14
DK0727898T3 (ru)	1997-03-17
DK126096A (ru)	1996-11-08
IN187634B (ru)	2002-06-01
BR7501503U (ru)	1997-11-25
BR7502120U (ru)	1998-04-14
IN179492B (ru)	1997-10-11
ECSDI950229S (ru)	1996-01-29
ECSDI950230S (ru)	1996-07-16
CN3034473S (ru)	1995-08-30
CN3036463S (ru)	1995-10-18
CN3035868S (ru)	1995-10-04
CN3035323S (ru)	1995-09-20
CN3034829S (ru)	1995-09-06
CN3034524S (ru)	1995-08-30
CN3035870S (ru)	1995-10-04
CN3033771S (ru)	1995-08-02
CN3033635S (ru)	1995-07-19